Cargando…
Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
The true onset of atherosclerosis remains one of the biggest challenges for cardiologists. Is atheroma plaque development considered the earliest step of vascular aging? If so, when it starts? Before or after birth? If it starts before birth or early during childhood, it seems that Thomas Sydenham w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574695/ https://www.ncbi.nlm.nih.gov/pubmed/28883714 http://dx.doi.org/10.2147/CIA.S141265 |
_version_ | 1783259891126763520 |
---|---|
author | Iurciuc, Stela Cimpean, Anca Maria Mitu, Florin Heredea, Rodica Iurciuc, Mircea |
author_facet | Iurciuc, Stela Cimpean, Anca Maria Mitu, Florin Heredea, Rodica Iurciuc, Mircea |
author_sort | Iurciuc, Stela |
collection | PubMed |
description | The true onset of atherosclerosis remains one of the biggest challenges for cardiologists. Is atheroma plaque development considered the earliest step of vascular aging? If so, when it starts? Before or after birth? If it starts before birth or early during childhood, it seems that Thomas Sydenham was right: “A man is as old as his arteries.” Except disorganization of elastic fibers, less is known about the morphology of vascular aging and also about the molecular events influencing the age of arteries, arterial stiffness, and their role in the appearance of future complications. Cellular and molecular events responsible for the switch from physiologic to pathologic aging of human arteries are less known. Epigenetic, genetic, and environmental influences at the onset of early vascular aging (EVA) should specifically influence the process. This paper briefly reviews the controversial data regarding vascular aging with an emphasis on the less known facts about the morphology of EVA. |
format | Online Article Text |
id | pubmed-5574695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-55746952017-09-07 Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? Iurciuc, Stela Cimpean, Anca Maria Mitu, Florin Heredea, Rodica Iurciuc, Mircea Clin Interv Aging Expert Opinion The true onset of atherosclerosis remains one of the biggest challenges for cardiologists. Is atheroma plaque development considered the earliest step of vascular aging? If so, when it starts? Before or after birth? If it starts before birth or early during childhood, it seems that Thomas Sydenham was right: “A man is as old as his arteries.” Except disorganization of elastic fibers, less is known about the morphology of vascular aging and also about the molecular events influencing the age of arteries, arterial stiffness, and their role in the appearance of future complications. Cellular and molecular events responsible for the switch from physiologic to pathologic aging of human arteries are less known. Epigenetic, genetic, and environmental influences at the onset of early vascular aging (EVA) should specifically influence the process. This paper briefly reviews the controversial data regarding vascular aging with an emphasis on the less known facts about the morphology of EVA. Dove Medical Press 2017-08-23 /pmc/articles/PMC5574695/ /pubmed/28883714 http://dx.doi.org/10.2147/CIA.S141265 Text en © 2017 Iurciuc et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Expert Opinion Iurciuc, Stela Cimpean, Anca Maria Mitu, Florin Heredea, Rodica Iurciuc, Mircea Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? |
title | Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? |
title_full | Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? |
title_fullStr | Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? |
title_full_unstemmed | Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? |
title_short | Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? |
title_sort | vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology? |
topic | Expert Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574695/ https://www.ncbi.nlm.nih.gov/pubmed/28883714 http://dx.doi.org/10.2147/CIA.S141265 |
work_keys_str_mv | AT iurciucstela vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology AT cimpeanancamaria vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology AT mituflorin vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology AT heredearodica vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology AT iurciucmircea vascularagingandsubclinicalatherosclerosiswhysuchaneverendingandchallengingstoryincardiology |